Page 341 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 16 Supportive Care for the Cancer Patient 319

for help, using the expertise of colleagues (i.e. client service coordina- 14. Hanisch UK, Kettenmann H: Microglia: active sensor and versa-
tors, veterinary nurses or client liaisons) to address clients’ concerns, tile effector cells in the normal and pathologic brain, Nat Neurosci
10:1387–1394, 2007.
to answer out-of-hours calls, and to provide support or counseling
VetBooks.ir if available to care for clients. Recognizing the signs of compassion 15. Zhou YQ, Liu Z, Liu HQ, et al.: Targeting glia for bone cancer
pain, Expert Opin Ther Targets 20:1365–1374, 2016.
fatigue is the first step toward positive change, and the second step is
making a daily, firm commitment to choices that lead to resiliency. 16. Huang ZX, Lu ZJ, Ma WQ, et al.: Involvement of RVM-expressed
P2X7 receptor in bone cancer pain: mechanism of descending facil-
The American Veterinary Medical Association provides resources for itation, Pain 155:783–791, 2014.
veterinary well-being on their website https://www.avma.org/Pro- 17. Mogil JS: Animal models of pain: progress and challenges, Nat Rev
fessionalDevelopment/PeerAndWellness/Pages/default.aspx. 468 Neurosci 10:283–294, 2009.
18. Dib-Hajj SD, Waxman SG: Translational pain research: lessons
Conclusion from genetics and genomics, Sci Transl Med 6;249sr4-249sr4,
2014.
Given the growing expectations of clients, the strength of the 19. Klinck MP, Mogil JS, Moreau M, et al.: Translational pain assess-
human-animal relationship, and the resultant emotional impact of ment: could natural animal models be the missing link? Pain
cancer communication on pet caregivers and the veterinary team, 158:1633–1646, 2017.
relationship-centered care is integral to providing quality cancer 20. Mogil JS: Laboratory environmental factors and pain behavior: the
relevance of unknown unknowns to reproducibility and transla-
care. 399,400,418,427,428 Compassionate cancer communication is tion, Lab Anim (NY) 46:136–141, 2017.
related to significant clinical outcomes for the veterinarian, client, and 21. Lascelles BDX: Surgical pain: pathophysiology, assessment and
439
patient, including enhancing client and veterinarian satisfaction, treatment strategies. In Tobias KMJS, editor: Veterinary surgery
438
437
improving adherence to recommendations, and working through small animal, St. Louis, 2012, Elsevier, pp 237–247.
emotions. 400,440 Effective techniques for cancer communication can 22. Brown DC, Nolan MW: Radiation therapy induced pain in dogs,
be taught and are a series of learned skills. 409–412 Through supportive PAWS Abstr 187, 2017.
approaches, cancer communication can be made less distressing to 23. Nolan MW, Long CT, Marcus KL, et al.: Nocifensive behaviors in
the client, fostering client relationships and optimizing patient care mice with radiation-induced oral mucositis, Radiat Res 187:397–
while promoting professional fulfillment for the veterinarian. 403, 2017.
24. Venable RO, Saba CF, Endicott MM, et al.: Dexrazoxane treat-
ment of doxorubicin extravasation injury in four dogs, J Am Vet
References Med Assoc 240:304–307, 2012.
25. Marker BA, Barber LG, Clifford CA, et al.: Extravasation reactions
1. Honore P, Rogers SD, Schwei MJ, et al.: Murine models of inflam- associated with the administration of pamidronate: 11 cases (2008–
matory, neuropathic and cancer pain each generates a unique set 2013), Vet Comp Oncol 15:470–480, 2017.
of neurochemical changes in the spinal cord and sensory neurons, 26. Bennett MI, Rayment C, Hjermstad M, et al.: Prevalence and aeti-
Neuroscience 98:585–598, 2000. ology of neuropathic pain in cancer patients: a systematic review,
2. Falk S, Dickenson AH: Pain and nociception: mechanisms of can- Pain 153:359–365, 2012.
cer-induced bone pain, J Clin Oncol 32:1647–1654, 2014. 27. Giglio P, Gilbert MR: Neurologic complications of cancer and its
3. Lam DK, Schmidt BL: Serine proteases and protease-activated treatment, Curr Oncol Rep 12:50–59, 2010.
receptor 2-dependent allodynia: a novel cancer pain pathway, Pain 28. Peters CM, Jimenez-Andrade JM, Jonas BM, et al.: Intravenous pacli-
149:263–272, 2010. taxel administration in the rat induces a peripheral sensory neuropa-
4. Schmidt BL: The neurobiology of cancer pain, J Oral Maxillofac thy characterized by macrophage infiltration and injury to sensory
Surg 73:S132–S135, 2015. neurons and their supporting cells, Exp Neurol 203:42–54, 2007.
5. Grivennikov SI, Greten FR, Karin M: Immunity, inflammation, 29. Zhang H, Yoon SY, Zhang H, et al.: Evidence that spinal astro-
and cancer, Cell 140:883–899, 2010. cytes but not microglia contribute to the pathogenesis of paclitaxel-
6. Yan L, Anderson GM, DeWitte M, et al.: Therapeutic potential of induced painful neuropathy, J Pain 13:293–303, 2012.
cytokine and chemokine antagonists in cancer therapy, Eur J Can- 30. Di Cesare Mannelli L, Pacini A, Bonaccini L, et al.: Morphologic
cer 42:793–802, 2006. features and glial activation in rat oxaliplatin-dependent neuro-
7. Song XJ, Lamotte RH, Xie Z: Regulation of cytokines in cancer pathic pain, J Pain 14:1585–1600, 2013.
pain, Mediators Inflamm 2–4, 2016. 31. Warwick RA, Hanani M: The contribution of satellite glial cells to
8. Descalzi G, Ikegami D, Ushijima T, et al.: Epigenetic mechanisms chemotherapy-induced neuropathic pain, Eur J Pain (United King-
of chronic pain, Trends Neurosci 38:237–246, 2015. dom) 17:571–580, 2013.
9. McMahon SB, Cafferty WBJ, Marchand F: Immune and glial cell 32. Flatters SJL, Bennett GJ: Studies of peripheral sensory nerves in
factors as pain mediators and modulators, Exp Neurol 192:444– paclitaxel-induced painful peripheral neuropathy: evidence for
462, 2005. mitochondrial dysfunction, Pain 122:245–257, 2006.
10. Donovan-Rodriguez T, Dickenson AH, Urch CE: Superficial 33. Joseph EK, Chen X, Bogen O, et al.: Oxaliplatin acts on IB4-posi-
dorsal horn neuronal responses and the emergence of behavioural tive nociceptors to induce an oxidative stress-dependent acute pain-
hyperalgesia in a rat model of cancer-induced bone pain, Neurosci ful peripheral neuropathy, J Pain 9:463–472, 2008.
Lett 360:29–32, 2004. 34. Xiao W, Boroujerdi A, Bennett GJ, et al.: Chemotherapy-evoked
11. Hald A, Nedergaard S, Hansen RR, et al.: Differential activation of painful peripheral neuropathy: analgesic effects of gabapentin and
spinal cord glial cells in murine models of neuropathic and cancer effects on expression of the alpha-2-delta type-1 calcium channel
pain, Eur J Pain 13:138–145, 2009. subunit, Neuroscience 144:714–720, 2007.
12. Yao M, Chang XY, Chu YX, et al.: Antiallodynic effects of propen- 35. Materazzi S, Fusi C, Benemei S, et al.: TRPA1 and TRPV4 mediate
tofylline elicited by interrupting spinal glial function in a rat model paclitaxel-induced peripheral neuropathy in mice via a glutathione-
of bone cancer pain, J Neurosci Res 89:1877–1886, 2011. sensitive mechanism, Pflugers Arch Eur J Physiol 463:561–569, 2012.
13. Wang LN, Yang JP, Zhan Y, et al.: Minocycline-induced reduc- 36. Sittl R, Lampert A, Huth T, et al.: Anticancer drug oxaliplatin
tion of brain-derived neurotrophic factor expression in relation induces acute cooling-aggravated neuropathy via sodium channel
to cancer-induced bone pain in rats, J Neurosci Res 90:672–681, subtype NaV1.6-resurgent and persistent current, Proc Natl Acad
2012. Sci 109:6704–6709, 2012.